Logo image of SIEN

SIENTRA INC (SIEN) Stock Fundamental Analysis

USA - NASDAQ:SIEN - US82621J2042 - Common Stock

0.174 USD
-0.04 (-18.69%)
Last: 2/21/2024, 8:07:31 PM
0.1798 USD
+0.01 (+3.33%)
After Hours: 2/21/2024, 8:07:31 PM
Fundamental Rating

1

SIEN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. SIEN has a bad profitability rating. Also its financial health evaluation is rather negative. SIEN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SIEN had negative earnings in the past year.
SIEN had a negative operating cash flow in the past year.
In the past 5 years SIEN always reported negative net income.
In the past 5 years SIEN always reported negative operating cash flow.
SIEN Yearly Net Income VS EBIT VS OCF VS FCFSIEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M -100M

1.2 Ratios

SIEN's Return On Assets of -42.26% is on the low side compared to the rest of the industry. SIEN is outperformed by 64.47% of its industry peers.
Industry RankSector Rank
ROA -42.26%
ROE N/A
ROIC N/A
ROA(3y)-42.93%
ROA(5y)-46.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SIEN Yearly ROA, ROE, ROICSIEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 5K 10K 15K

1.3 Margins

SIEN has a worse Gross Margin (42.12%) than 62.94% of its industry peers.
SIEN's Gross Margin has declined in the last couple of years.
SIEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.81%
GM growth 5Y-5.59%
SIEN Yearly Profit, Operating, Gross MarginsSIEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

SIEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
SIEN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, SIEN has a worse debt to assets ratio.
SIEN Yearly Shares OutstandingSIEN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M
SIEN Yearly Total Debt VS Total AssetsSIEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -8.45, we must say that SIEN is in the distress zone and has some risk of bankruptcy.
SIEN's Altman-Z score of -8.45 is on the low side compared to the rest of the industry. SIEN is outperformed by 74.62% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.45
ROIC/WACCN/A
WACC5.68%
SIEN Yearly LT Debt VS Equity VS FCFSIEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 0.57 indicates that SIEN may have some problems paying its short term obligations.
SIEN has a Current ratio of 0.57. This is amonst the worse of the industry: SIEN underperforms 95.94% of its industry peers.
SIEN has a Quick Ratio of 0.57. This is a bad value and indicates that SIEN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SIEN (0.31) is worse than 97.97% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.31
SIEN Yearly Current Assets VS Current LiabilitesSIEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

SIEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.90%, which is quite impressive.
The Revenue has been growing slightly by 2.46% in the past year.
The Revenue has been growing by 19.90% on average over the past years. This is quite good.
EPS 1Y (TTM)48.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.42%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y2.66%
Revenue growth 5Y19.9%
Sales Q2Q%-13.42%

3.2 Future

The Earnings Per Share is expected to grow by 23.71% on average over the next years. This is a very strong growth
SIEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.11% yearly.
EPS Next Y61.42%
EPS Next 2Y34.93%
EPS Next 3Y23.71%
EPS Next 5YN/A
Revenue Next Year-3.12%
Revenue Next 2Y1.1%
Revenue Next 3Y5.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SIEN Yearly Revenue VS EstimatesSIEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
SIEN Yearly EPS VS EstimatesSIEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SIEN. In the last year negative earnings were reported.
Also next year SIEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SIEN Price Earnings VS Forward Price EarningsSIEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SIEN Per share dataSIEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

SIEN's earnings are expected to grow with 23.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.93%
EPS Next 3Y23.71%

More info and screens

0

5. Dividend

5.1 Amount

SIEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIENTRA INC

NASDAQ:SIEN (2/21/2024, 8:07:31 PM)

After market: 0.1798 +0.01 (+3.33%)

0.174

-0.04 (-18.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-09 2023-11-09/amc
Earnings (Next)03-12 2024-03-12/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners40.75%
Ins Owner Change0%
Market Cap2.08M
Analysts82.22
Price Target2.04 (1072.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.79%
Min EPS beat(2)-47.06%
Max EPS beat(2)3.47%
EPS beat(4)2
Avg EPS beat(4)-25.12%
Min EPS beat(4)-71.93%
Max EPS beat(4)15.05%
EPS beat(8)2
Avg EPS beat(8)-23.45%
EPS beat(12)3
Avg EPS beat(12)-40.03%
EPS beat(16)5
Avg EPS beat(16)-33.19%
Revenue beat(2)0
Avg Revenue beat(2)-8.6%
Min Revenue beat(2)-8.82%
Max Revenue beat(2)-8.39%
Revenue beat(4)0
Avg Revenue beat(4)-5.78%
Min Revenue beat(4)-8.82%
Max Revenue beat(4)-2.46%
Revenue beat(8)3
Avg Revenue beat(8)-3.5%
Revenue beat(12)4
Avg Revenue beat(12)-3.58%
Revenue beat(16)6
Avg Revenue beat(16)-4.2%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)6.49%
EPS NQ rev (3m)6.49%
EPS NY rev (1m)0%
EPS NY rev (3m)-25.87%
Revenue NQ rev (1m)-1.86%
Revenue NQ rev (3m)-1.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.57
EYN/A
EPS(NY)-1.89
Fwd EYN/A
FCF(TTM)-1.18
FCFYN/A
OCF(TTM)-0.95
OCFYN/A
SpS7.55
BVpS-2.68
TBVpS-5.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.12%
FCFM N/A
ROA(3y)-42.93%
ROA(5y)-46.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.81%
GM growth 5Y-5.59%
F-Score3
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.54%
Cap/Sales 3.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.31
Altman-Z -8.45
F-Score3
WACC5.68%
ROIC/WACCN/A
Cap/Depr(3y)86.32%
Cap/Depr(5y)80.1%
Cap/Sales(3y)5.3%
Cap/Sales(5y)4.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.42%
EPS Next Y61.42%
EPS Next 2Y34.93%
EPS Next 3Y23.71%
EPS Next 5YN/A
Revenue 1Y (TTM)2.46%
Revenue growth 3Y2.66%
Revenue growth 5Y19.9%
Sales Q2Q%-13.42%
Revenue Next Year-3.12%
Revenue Next 2Y1.1%
Revenue Next 3Y5.11%
Revenue Next 5YN/A
EBIT growth 1Y9.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year68.29%
EBIT Next 3Y27.15%
EBIT Next 5YN/A
FCF growth 1Y66.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.23%
OCF growth 3YN/A
OCF growth 5YN/A